Latin American Consensus on the Treatment of Head and Neck Cancer.
Leandro Luongo de MatosLuiz Paulo KowalskiAline Lauda Freitas ChavesThiago Bueno de OliveiraGustavo Nader MartaMaria Paula CuradoGilberto de Castro JuniorTerence P FariasGustavo Sarria BardalesMario Avila CabreraRenato de Castro CapuzzoGenival Barbosa de CarvalhoClaudio Roberto CerneaRogerio Aparecido DedivitisFernando Luiz DiasAndrés Munyo EstefanAgustin Horacio FalcoGustavo Alberto FerrarisAlejandro Gonzalez-MottaAndré Guimarães GouveiaAlexandre Arthur JacintoMarco Aurelio Valmondes KulcsarAna Kober Nogueira LeiteRenan Bezerra LiraMilena Perez MakPedro De MarchiEvandro Sobroza de MelloFatima Cristina Mendes de MatosPablo H MonteroEduardo Dias de MoraesFabio Ynoe de MoraesDiego Chaves Rezende MoraisFernando Miguel PoenitzAdela PoitevinHernán Ortiz RiverosÁlvaro SanabriaMiguel Ticona-CastroJose Guilherme VartanianGustavo Arruda VianiEugenio F VinesWilliam Nassib William JuniorDavid I ConwayShama ViraniPaul J Brennannull nullPublished in: JCO global oncology (2024)
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be applied to a population from a large region with specific conditions. This study established a Latin American guideline for care of patients with head and neck cancer and presented evidence of HNSCC management considering availability and oncologic benefit. A panel composed of 41 head and neck cancer experts systematically worked according to a modified Delphi process on (1) document compilation of evidence-based answers to different questions contextualized by resource availability and oncologic benefit regarding Latin America (region of limited resources and/or without access to all necessary health care system infrastructure), (2) revision of the answers and the classification of levels of evidence and degrees of recommendations of all recommendations, (3) validation of the consensus through two rounds of online surveys, and (4) manuscript composition. The consensus consists of 12 sections: Head and neck cancer staging, Histopathologic evaluation of head and neck cancer, Head and neck surgery-oral cavity, Clinical oncology-oral cavity, Head and neck surgery-oropharynx, Clinical oncology-oropharynx, Head and neck surgery-larynx, Head and neck surgery-larynx/hypopharynx, Clinical oncology-larynx/hypopharynx, Clinical oncology-recurrent and metastatic head and neck cancer, Head and neck surgery-reconstruction and rehabilitation, and Radiation therapy. The present consensus established 48 recommendations on HNSCC patient care considering the availability of resources and focusing on oncologic benefit. These recommendations could also be used to formulate strategies in other regions like Latin America countries.
Keyphrases
- minimally invasive
- clinical practice
- coronary artery bypass
- palliative care
- radiation therapy
- healthcare
- surgical site infection
- robot assisted
- public health
- small cell lung cancer
- squamous cell carcinoma
- machine learning
- prostate cancer
- deep learning
- total knee arthroplasty
- lymph node
- risk assessment
- coronary artery disease
- smoking cessation
- combination therapy
- cross sectional
- climate change